| Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression S Cao, JR Wang, S Ji, P Yang, Y Dai, S Guo, MD Montierth, JP Shen, ... Nature biotechnology, 1-10, 2022 | 41 | 2022 |
| Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma JR Wang, M Montierth, L Xu, M Goswami, X Zhao, G Cote, W Wang, P Iyer, ... JCO Precision Oncology 6, e2100504, 2022 | 30 | 2022 |
| Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis DK Johnson, KM Reynolds, BD Poole, MD Montierth, VM Todd, ... Plos one 16 (1), e0243150, 2021 | 9 | 2021 |
| The impact of multiple sclerosis disease status and subtype on hematological profile JM Miller, JT Beales, MD Montierth, FB Briggs, SF Frodsham, MF Davis International journal of environmental research and public health 18 (6), 3318, 2021 | 7 | 2021 |
| A pedigree-based prediction model identifies carriers of deleterious de novo mutations in families with Li-Fraumeni syndrome F Gao, X Pan, EB Dodd-Eaton, CV Recio, MD Montierth, J Bojadzieva, ... Genome research 30 (8), 1170-1180, 2020 | 5 | 2020 |
| Reactivation of the G1 enhancer landscape underlies core circuitry addiction to SWI/SNF K Cermakova, L Tao, M Dejmek, M Sala, MD Montierth, YS Chan, I Patel, ... Nucleic Acids Research, gkad1081, 2023 | 2 | 2023 |
| CliP: subclonal architecture reconstruction of cancer cells in DNA sequencing data using a penalized likelihood model Y Jiang, K Yu, S Ji, SJ Shin, S Cao, MD Montierth, L Huang, S Kopetz, ... bioRxiv, 2021 | 2 | 2021 |
| Tumor cell total mRNA expression shapes the molecular and clinical phenotype of cancer S Cao, JR Wang, S Ji, P Yang, MD Montierth, S Guo, JP Shen, X Zhao, ... bioRxiv, 2020.09. 30.306795, 2021 | 2 | 2021 |
| MuSE: A Novel Approach to Mutation Calling with Sample-Specific Error Modeling S Ji, MD Montierth, W Wang Variant Calling: Methods and Protocols, 21-27, 2022 | 1 | 2022 |
| Pan-cancer analysis of intra-tumor heterogeneity in 9,116 cancers using a novel regularized likelihood model Y Jiang, K Yu, MD Montierth, S Ji, SJ Shin, S Guo, S Cao, Y Tang, ... Cancer Research 83 (7_Supplement), 4272-4272, 2023 | | 2023 |
| Accelerated somatic mutation calling tool for whole-genome and whole-exome sequencing data from heterogenous tumor samples S Ji, T Zhu, A Sethia, MD Montierth, W Wang Cancer Research 83 (7_Supplement), 2070-2070, 2023 | | 2023 |
| DeMixMir: deconvolution of microRNA sequencing data from heterogeneous tumor samples M Montierth, K Nemeth, X Tao, G Calin, W Wang Cancer Research 83 (7_Supplement), 3773-3773, 2023 | | 2023 |
